The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
“Democratizing” cancer care: City of Hope’s national enterprise model for delivering cancer care.
 
Jeffrey Schriber
Employment - Cancer Treament Centers of America
Stock and Other Ownership Interests - Adaptive Therapeutics; atra; Beam Therapeutics; Bristol-Myers Squibb; Crispr Therapeutics; Genmab/Seattle Genetics; Guardant Health; KPTI; Seattle Genetics/Astellas
Honoraria - Curio Science; Seattle Genetics/Astellas
Consulting or Advisory Role - GlaxoSmithKline; Jazz Pharmaceuticals
Speakers' Bureau - AstraZeneca; BeiGene; Bristol-Myers Squibb; Epizyme; Karyopharm Therapeutics; Seattle Genetics/Astellas
 
Andrew S. Artz
Stock and Other Ownership Interests - Radiology Partners (I)
Consulting or Advisory Role - Abbvie; Magenta Therapeutics
 
Amy Purvis
Consulting or Advisory Role - Curio Science
 
James L. Slack
Employment - Cancer Treament Centers of America
 
Jeremy Todd Larsen
Employment - Cancer Treament Centers of America
Consulting or Advisory Role - Janssen Biotech
Speakers' Bureau - Janssen
 
Soyoung Park
Employment - Cancer Treament Centers of America
 
Kevin Frank Tulipana
Employment - Cancer Treament Centers of America
 
Gemini Majkowski
Consulting or Advisory Role - Cancer Treament Centers of America
 
Ryotaro Nakamura
No Relationships to Disclose
 
Leslie Popplewell
Honoraria - ADC Therapeutics; Kite, a Gilead company
 
Alex Francisco Herrera
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Adicet Bio; AstraZeneca/MedImmune; Bristol-Myers Squibb; Caribou Biosciences; Genentech/Roche; Genmab; Karyopharm Therapeutics; Merck; Pfizer; Regeneron; Seagen; Takeda; Tubulis GmbH
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Lihua Elizabeth Budde
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; BeiGene; Kite/Gilead; Loxo/Lilly; Novartis; nurix; Roche/Genentech
Research Funding - Amgen; AstraZeneca; Merck; MustangBio
Patents, Royalties, Other Intellectual Property - CCR4 CAR T cells for treatment of patients with CCR4 positive cancer.; CD33CAR for treatment of patients with CD33+ acute myeloid leukemia.
Travel, Accommodations, Expenses - Kite/Gilead; Roche/Genentech
 
Paul B. Koller
Honoraria - Clinical Care targeted communications
Consulting or Advisory Role - Ascentage Pharma; Daiichi Sankyo; Novartis
Speakers' Bureau - Novartis; Takeda/Millennium
 
Murali Janakiram
Consulting or Advisory Role - Janssen
 
Brian Ball
No Relationships to Disclose
 
Tycel Jovelle Phillips
Honoraria - Lymphoma & Myeloma Connect; Seagen
Consulting or Advisory Role - ADC Therapeutics; Bayer; Celgene; Curis; Genentech; Genmab; Gilead Sciences; Incyte; Kite/Gilead; Lilly; Pharmacyclics; Seagen; TG Therapeutics
Research Funding - Abbvie; Bayer; Genentech; Pharmacyclics/Janssen
 
Michael Alan Rosenzweig
Speakers' Bureau - Bristol Myers Squibb Foundation; Janssen
Research Funding - Janssen; Pfizer
 
Guido Marcucci
No Relationships to Disclose
 
Eileen P. Smith
No Relationships to Disclose
 
Forrest Stewart
No Relationships to Disclose